文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Lars H Lund
发表
Rationale and design of ENDEAVOR: A sequential phase 2b–3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction
B. Merkely, E. Michaëlsson, H. Ericsson, 2023, European journal of heart failure.